'First, do no harm': Managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer
Version 2 2024-06-03, 09:54Version 2 2024-06-03, 09:54
Version 1 2016-02-01, 00:00Version 1 2016-02-01, 00:00
journal contribution
posted on 2024-06-03, 09:54 authored by AJ Lomax, P Parente, C Gilfillan, Trish LivingstonTrish Livingston, ID Davis, C Pezaro'First, do no harm': Managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer
History
Related Materials
- 1.
Location
AustraliaLanguage
EnglishPublication classification
C Journal article, C1 Refereed article in a scholarly journalCopyright notice
2016, WileyJournal
Internal Medicine JournalVolume
46Pagination
141-148ISSN
1444-0903eISSN
1445-5994Issue
2Publisher
WILEYUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal Medicineadvanced prostate cancerandrogen deprivation therapymetabolic complicationsupportive careINDUCED BONE LOSSBODY-COMPOSITIONDOUBLE-BLINDTHERAPYABIRATERONESURVIVALPREVENTIONENZALUTAMIDEOSTEOPOROSISALENDRONATESchool of Nursing and MidwiferyFaculty of Health920102 Cancer and Related Disorders3211 Oncology and carcinogenesis
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC

